EVERSANA and Waltz Health Merger: Redefining Pharma Commercialization
EVERSANA and Waltz Health announced a merger today to form a unified healthcare platform designed to redefine pharmaceutical commercialization...
regulatory approval
Advertisement
Harmony Biosciences to Spotlight Rare Epilepsy Pipeline at International Epilepsy Congress
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) announced today that it will present new clinical data on its investigational therapy...
CorrectSequence Therapeutics Promising Results for World’s First Cure of Sickle Cell via transformer Base Editing
Shanghai, China, August 26, 2025 – In a landmark advancement, CorrectSequence Therapeutics Co., Ltd. (Correctseq) has announced the first...
Sanofi’s Rilzabrutinib Gets EU Orphan Drug Status for IgG4-Related Disease
Paris, August 14, 2025 – The European Medicines Agency (EMA) has granted orphan drug designation to Sanofi’s rilzabrutinib, a...
Advertisement
